South Africa's health regulator to assess efficacy of Sinopharm vaccine
The Peninsula
JOHANNESBURG - South Africa's health regulator said on Wednesday it had received documentation for China's Sinopharm COVID-19 vaccine and will evaluate the data to assess the efficacy of the shot.
Now in the grip of a third wave of infections, South Africa is inoculating its population with Johnson & Johnson and Pfizer vaccines, but the rollout has been slow partly due to setbacks in supply. It has vaccinated just over 2 million people, 3.6% of its population, one of the world's lowest rates.More Related News